Download PDF
J Pediatr Intensive Care 2021; 10(04): 271-275
DOI: 10.1055/s-0040-1716579
Original Article

Practice Variability in Screening and Treating Pediatric Critical Illness Delirium: Survey

Salim Aljabari 
1   Department of Child Health, University of Missouri-Columbia, Missouri, United States
,
Cara Carter 
2   Department of Clinical Pharmacology, University of Missouri-Columbia Women's and Children's Hospital, Columbia, Missouri, United States
,
Shahzad Waheed
1   Department of Child Health, University of Missouri-Columbia, Missouri, United States
,
Jordan E. Anderson
2   Department of Clinical Pharmacology, University of Missouri-Columbia Women's and Children's Hospital, Columbia, Missouri, United States
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

The best practice in pediatric delirium (PD) screening and treatment is still unknown. Current recommendations come from small studies and adult data. In this article, we surveyed the Pediatric Critical Care Medicine fellowship directors on PD screening and treatment practices in their centers. We reported high variability in the screening and treatment practices for PD in large academic medical centers in the United States. The Cornell Assessment of Pediatric Delirium tool is the most commonly used tool for screening, and quetiapine is the most commonly used pharmacologic agent. A national guideline on PD screening, prevention, and treatment is needed to standardize practice and provide guidance.

Keywords

delirium - critical care - pediatric - intensive care units - children - screening

Supplementary Material



Publication History

Received: 02 July 2020

Accepted: 06 August 2020

Article published online:
07 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Silver G, Traube C, Gerber LM. et al. Pediatric delirium and associated risk factors: a single-center prospective observational study. Pediatr Crit Care Med 2015; 16 (04) 303-309
    CrossrefPubMedGoogle Scholar
  • 2 Joyce C, Witcher R, Herrup E. et al. Evaluation of the safety of quetiapine in treating delirium in critically ill children: a retrospective review. J Child Adolesc Psychopharmacol 2015; 25 (09) 666-670
    CrossrefPubMedGoogle Scholar
  • 3 Smith HAB, Gangopadhyay M, Goben CM. et al. Delirium and benzodiazepines associated with prolonged ICU stay in critically ill infants and young children. Crit Care Med 2017; 45 (09) 1427-1435
    CrossrefPubMedGoogle Scholar
  • 4 Harris J, Ramelet AS, van Dijk M. et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med 2016; 42 (06) 972-986
    CrossrefPubMedGoogle Scholar
  • 5 Traube C, Silver G, Reeder RW. et al. Delirium in critically ill children: an international point prevalence study. Crit Care Med 2017; 45 (04) 584-590
    CrossrefPubMedGoogle Scholar
  • 6 Traube C, Silver G, Gerber LM. et al. Delirium and mortality in critically Ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med 2017; 45 (05) 891-898
    CrossrefPubMedGoogle Scholar
  • 7 Patel AK, Bell MJ, Traube C. Delirium in pediatric critical care. Pediatr Clin North Am 2017; 64 (05) 1117-1132
    CrossrefPubMedGoogle Scholar
  • 8 Silver GH, Kearney JA, Bora S. PATHWAYS FOR CLINICAL CARE WORKGROUP, et al. A clinical pathway to standardize care of children with delirium in pediatric inpatient settings. Hosp Pediatr 2019; 9 (11) 909-916
    CrossrefPubMedGoogle Scholar
  • 9 Traube C, Mauer EA, Gerber LM. et al. Cost associated with pediatric delirium in the ICU. Crit Care Med 2016; 44 (12) e1175-e1179
    CrossrefPubMedGoogle Scholar
  • 10 Girard TD, Jackson JC, Pandharipande PP. et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010; 38 (07) 1513-1520
    CrossrefPubMedGoogle Scholar
  • 11 Meyburg J, Ries M, Zielonka M. et al. Cognitive and behavioral consequences of pediatric delirium: a pilot study. Pediatr Crit Care Med 2018; 19 (10) e531-e537
    CrossrefPubMedGoogle Scholar
  • 12 Malas N, Brahmbhatt K, McDermott C, Smith A, Ortiz-Aguayo R, Turkel S. Pediatric delirium: evaluation, management, and special considerations. Curr Psychiatry Rep 2017; 19 (09) 65
    CrossrefPubMedGoogle Scholar
  • 13 Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community*. Crit Care Med 2014; 42 (07) 1592-1600
    CrossrefPubMedGoogle Scholar
  • 14 Kishk OA, Simone S, Lardieri AB, Graciano AL, Tumulty J, Edwards S. Antipsychotic treatment of delirium in critically ill children: a retrospective matched cohort study. J Pediatr Pharmacol Ther 2019; 24 (03) 204-213
    PubMedGoogle Scholar
  • 15 Van Cauteren YJ, Van Tuijl SG, Schieveld JN. The need for an international standardized guideline regarding pediatric delirium--reply to the letter by giusti et al. Minerva Anestesiol 2015; 81 (04) 462-463
    PubMedGoogle Scholar
  • 16 Winsnes K, Sochacki P, Eriksson C. et al. Delirium in the pediatric hematology, oncology, and bone marrow transplant population. Pediatr Blood Cancer 2019; 66 (06) e27640
    CrossrefPubMedGoogle Scholar
  • 17 Turkel SB. Pediatric delirium: recognition, management, and outcome. Curr Psychiatry Rep 2017; 19 (12) 101
    CrossrefPubMedGoogle Scholar
  • 18 Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology 2004; 100 (05) 1138-1145
    CrossrefPubMedGoogle Scholar
  • 19 Smith HA, Boyd J, Fuchs DC. et al. Diagnosing delirium in critically ill children: validity and reliability of the pediatric confusion assessment method for the intensive care unit. Crit Care Med 2011; 39 (01) 150-157
    CrossrefPubMedGoogle Scholar
  • 20 Smith HA, Gangopadhyay M, Goben CM. et al. The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically ill infants and children. Crit Care Med 2016; 44 (03) 592-600
    CrossrefPubMedGoogle Scholar
  • 21 Silver G, Traube C, Kearney J. et al. Detecting pediatric delirium: development of a rapid observational assessment tool. Intensive Care Med 2012; 38 (06) 1025-1031
    CrossrefPubMedGoogle Scholar
  • 22 Traube C, Silver G, Kearney J. et al. Cornell assessment of pediatric delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med 2014; 42 (03) 656-663
    CrossrefPubMedGoogle Scholar
  • 23 Campbell CT, Grey E, Munoz-Pareja J, Manasco KB. An evaluation of risperidone dosing for pediatric delirium in children less than or equal to 2 years of age. Ann Pharmacother 2020; 54 (05) 464-469
    CrossrefPubMedGoogle Scholar
  • 24 Barr J, Fraser GL, Puntillo K. American College of Critical Care Medicine, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41 (01) 263-306
    CrossrefPubMedGoogle Scholar
  • 25 Turkel SB, Jacobson J, Munzig E, Tavaré CJ. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. J Child Adolesc Psychopharmacol 2012; 22 (02) 126-130
    CrossrefPubMedGoogle Scholar
  • 26 Van Tuijl SG, Van Cauteren YJ, Pikhard T, Engel M, Schieveld JN. Management of pediatric delirium in critical illness: a practical update. Minerva Anestesiol 2015; 81 (03) 333-341
    PubMedGoogle Scholar
  • 27 Daoud A, Duff JP, Joffe AR. Alberta Sepsis Network. Diagnostic accuracy of delirium diagnosis in pediatric intensive care: a systematic review. Crit Care 2014; 18 (05) 489
    CrossrefPubMedGoogle Scholar
  • 28 Sassano-Higgins S, Freudenberg N, Jacobson J, Turkel S. Olanzapine reduces delirium symptoms in the critically ill pediatric patient. J Pediatr Intensive Care 2013; 2 (02) 49-54
    PubMedGoogle Scholar
  • 29 Devlin JW, Roberts RJ, Fong JJ. et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38 (02) 419-427
    CrossrefPubMedGoogle Scholar
  • 30 Slooff VD, Spaans E, van Puijenbroek E. et al. Adverse events of haloperidol for the treatment of delirium in critically ill children. Intensive Care Med 2014; 40 (10) 1602-1603
    CrossrefPubMedGoogle Scholar
  • 31 Bettencourt A, Mullen JE. Delirium in Children: Identification, Prevention, and Management. Crit Care Nurse 2017; 37 (03) e9-e18
    CrossrefPubMedGoogle Scholar
  • 32 Turkel SB, Hanft A. The pharmacologic management of delirium in children and adolescents. Paediatr Drugs 2014; 16 (04) 267-274
    CrossrefPubMedGoogle Scholar
  • 33 Capino AC, Thomas AN, Baylor S, Hughes KM, Miller JL, Johnson PN. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. J Pediatr Pharmacol Ther 2020; 25 (02) 81-95
    PubMedGoogle Scholar
  • 34 Traube C, Witcher R, Mendez-Rico E, Silver G. Quetiapine as treatment for delirium in critically ill children: a case series. J Pediatr Intensive Care 2013; 2 (03) 121-126
    PubMedGoogle Scholar
  • 35 Rasimas JJ, Liebelt EL. Adverse effects and toxicity of the atypical antipsychotics: what is important for the pediatric emergency medicine practitioner. Clin Pediatr Emerg Med 2012; 13 (04) 300-310
    CrossrefPubMedGoogle Scholar